Search Results
Focus in NeuroDevelopment (FIND) Network: A Statewide Network for Research in Neurodevelopment
The purpose of this research project is to develop a registry and database of families with neurodevelopmental disorders.
• All ages
• All individuals with disabilities and families within the neurodevelopmental disorder community
• Also looking for clinicians, educators, and professionals in the field
D2D Kid Talk Study: How Do Kids Learn Language?
This study will provide preliminary evidence regarding the relationship between metalinguistic awareness, language development, and language learning. We will enroll up to 800 5- to 8-year-old typically developing children who speak English. Child participants will complete problem solving and language-based tasks. Study results will inform interventions for children with significant language-learning weaknesses.
Gender Identity Measurement In Early School Aged Children
This study investigates the links between gender and executive function, specifically flexible thinking and creativity. It also assesses parents' reasoning behind nonparticipation, and children's responses to gender identity measures.
• Ages 5 to 8
• English speaking
• unable to speak English
HM2023-11 PH I study of ven/aza or ven in combination with ziftomenib (KO-539) or 7+3 induction chemo with ziftomenib for AML pts
There are certain genetic changes in the leukemia cell thought to drive the disease in patients with acute myeloid leukemia. Ziftomenib is an investigational drug that blocks the menin pathway in hopes of preventing or slowing the leukemia cells from growing and dividing. The purpose of this study is to determine the safe dose of an investigational new drug (ziftomenib) used in combination with other study drugs i.e., venetoclax and azacitidine, to treat cancer. This will include an evaluation of side effects associated with ziftomenib in combination with the other study drugs and how ziftomenib works in combination with the other study drugs (venetoclax and azacitidine).
• newly diagnosed or relapsed/refractory Acute Myeloid Leukemia (AML) with specific mutation (study staff will review)
• able to walk and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours
• adequate liver, renal, and cardiac function
• women and men of child bearing age must follow specific requirements for birth control
• other types of leukemia
• active involvement of central nervous system
• clinically active human immunodeficiency virus, active hepatitis B or active hepatitis C infection
• women who are pregnant or breast feeding
• additional criteria (study staff will review)
D2D Care Aware: Understanding Opioids in Minnesota
According to the Minnesota Department of Human Services, about 290,000 adults in Minnesota need treatment for addiction. National data suggests that only 10% of those who need treatment receive it. Through a 15 minute survey, we want to assess the public's view and understanding of opioid addiction and treatment options, including familiarity with harm reduction and support for public health policy on addiction.